QHSLab, Inc. (USAQ) intrinsic value & 10-year financials

QHSLab, Inc. (USAQ) has a Graham intrinsic value of $0.66 per share. At $0.32 on Oct 17, 2026, the stock trades 52% below that value. Over the last 10 fiscal years revenue grew 84.9% a year to $2.7M, with an average return on invested capital of -61.5%.

Graham intrinsic value
$0.66
Share price (Oct 17, 2026)
$0.32
Price vs Graham value
52% below
Market cap
$6.2M
Revenue (FY2025)
$2.7M
Revenue growth (10-yr CAGR)
84.9%
ROIC (10-yr avg)
-61.5%
Free cash flow (FY2025)
—

USAQ 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $2.7M $457.4K $0.02 — 4.9% 42.4%
FY2024 $2.1M -$259.2K -$0.03 — 9.7% -218.1%
FY2023 $1.4M -$468.4K -$0.05 — -17.0% -261.1%
FY2022 $1.2M -$996.0K -$0.11 — -45.1% -193.2%
FY2021 $1.4M -$770.2K — — -35.5% -97.4%
FY2020 $124.5K -$327.4K — — -238.0% 63.1%
FY2019 — -$166.5K — — — 34.6%
FY2018 — -$38.6K — — — 7.5%
FY2017 — -$11.4K — — — 2.3%
FY2016 — -$23.2K — — — 4.8%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

QHSLab, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

QHSLab, Inc. has historically struggled to out-earn its cost of capital, averaging just 5.1% ROIC.

QHSLab, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, QHSLab, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.66 per share.

USAQ stock: frequently asked questions

What is the intrinsic value of QHSLab, Inc. (USAQ) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, USAQ's intrinsic value is about $0.66 per share.

Is USAQ stock undervalued?

At $0.32 (close on Oct 17, 2026), USAQ trades 52% below its Graham value of $0.66. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

What is USAQ's return on invested capital?

Average ROIC over the last 10 fiscal years was -61.5%, and average return on equity was -36.7%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this USAQ data come from?

From QHSLab, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 14, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks